share_log

Does Shenzhen FRD Science & Technology (SZSE:300602) Have A Healthy Balance Sheet?

Does Shenzhen FRD Science & Technology (SZSE:300602) Have A Healthy Balance Sheet?

深圳富瑞达科技(SZSE:300602)是否拥有健康的资产负债表?
Simply Wall St ·  09/06 19:01

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We note that Shenzhen FRD Science & Technology Co., Ltd. (SZSE:300602) does have debt on its balance sheet. But the real question is whether this debt is making the company risky.

传奇基金经理李露(由查理·芒格支持)曾经说过:“最大的投资风险不是价格的波动,而是你是否会遭受永久的资本损失。”当我们思考一家公司的风险有多大时,我们总是喜欢考虑其债务的用途,因为债务过载可能导致破产。我们注意到,深圳富瑞德科技股份有限公司(SZSE: 300602)的资产负债表上确实有债务。但真正的问题是这笔债务是否使公司面临风险。

Why Does Debt Bring Risk?

为什么债务会带来风险?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

一般而言,只有当公司无法通过筹集资金或用自己的现金流轻松还清债务时,债务才会成为真正的问题。资本主义的组成部分是 “创造性破坏” 过程,在这种过程中,倒闭的企业被银行家无情地清算。但是,更常见(但仍然昂贵)的情况是,公司为了控制债务,必须以低廉的股价稀释股东。但是,通过取代稀释,对于需要资本以高回报率投资增长的企业来说,债务可以成为一个非常好的工具。当我们考虑公司使用债务时,我们首先将现金和债务放在一起考虑。

How Much Debt Does Shenzhen FRD Science & Technology Carry?

深圳FRD科技背负了多少债务?

You can click the graphic below for the historical numbers, but it shows that Shenzhen FRD Science & Technology had CN¥1.30b of debt in June 2024, down from CN¥1.96b, one year before. However, it does have CN¥1.31b in cash offsetting this, leading to net cash of CN¥8.03m.

你可以点击下图查看历史数字,但它显示深圳富力达科技在2024年6月的债务为13元人民币,低于一年前的19.6元人民币。但是,它确实有13.1元人民币的现金抵消了这一点,净现金为803万元人民币。

big
SZSE:300602 Debt to Equity History September 6th 2024
SZSE: 300602 债券与股本的比率记录 2024 年 9 月 6 日

A Look At Shenzhen FRD Science & Technology's Liabilities

看看深圳富力达科技的负债

Zooming in on the latest balance sheet data, we can see that Shenzhen FRD Science & Technology had liabilities of CN¥2.77b due within 12 months and liabilities of CN¥767.7m due beyond that. Offsetting this, it had CN¥1.31b in cash and CN¥2.05b in receivables that were due within 12 months. So its liabilities total CN¥185.2m more than the combination of its cash and short-term receivables.

放大最新的资产负债表数据,我们可以看到,深圳富力达科技在12个月内到期的负债为27.7元人民币,在此之后到期的负债为76770万元人民币。与此相抵消的是,它有13.1元人民币的现金和20.5元人民币的应收账款将在12个月内到期。因此,其负债总额为18520万元人民币,超过了现金和短期应收账款的总和。

Of course, Shenzhen FRD Science & Technology has a market capitalization of CN¥8.15b, so these liabilities are probably manageable. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward. Despite its noteworthy liabilities, Shenzhen FRD Science & Technology boasts net cash, so it's fair to say it does not have a heavy debt load!

当然,深圳FRD科技的市值为81.5元人民币,因此这些负债可能是可以控制的。但是,有足够的负债,我们肯定会建议股东今后继续监督资产负债表。尽管负债值得关注,但深圳富力达科技拥有净现金,因此可以公平地说,它没有沉重的债务负担!

Better yet, Shenzhen FRD Science & Technology grew its EBIT by 930% last year, which is an impressive improvement. That boost will make it even easier to pay down debt going forward. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if Shenzhen FRD Science & Technology can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

更好的是,深圳FRD科技去年的息税前利润增长了930%,这是一个令人印象深刻的改善。这种提振将使未来偿还债务变得更加容易。毫无疑问,我们从资产负债表中学到的关于债务的知识最多。但最终,该业务的未来盈利能力将决定深圳FRD Science & Technology能否随着时间的推移加强其资产负债表。因此,如果您专注于未来,可以查看这份显示分析师利润预测的免费报告。

Finally, a company can only pay off debt with cold hard cash, not accounting profits. While Shenzhen FRD Science & Technology has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. During the last two years, Shenzhen FRD Science & Technology burned a lot of cash. While investors are no doubt expecting a reversal of that situation in due course, it clearly does mean its use of debt is more risky.

最后,公司只能用冷硬现金偿还债务,不能用会计利润偿还债务。尽管深圳FRD Science & Technology的资产负债表上有净现金,但仍值得一看其将利息税前收益(EBIT)转换为自由现金流的能力,以帮助我们了解其建立(或侵蚀)现金余额的速度有多快。在过去的两年中,深圳FRD科技消耗了大量现金。尽管投资者无疑预计这种情况将在适当的时候逆转,但这显然意味着其使用债务的风险更大。

Summing Up

总结

While it is always sensible to look at a company's total liabilities, it is very reassuring that Shenzhen FRD Science & Technology has CN¥8.03m in net cash. And we liked the look of last year's 930% year-on-year EBIT growth. So we are not troubled with Shenzhen FRD Science & Technology's debt use. Over time, share prices tend to follow earnings per share, so if you're interested in Shenzhen FRD Science & Technology, you may well want to click here to check an interactive graph of its earnings per share history.

尽管查看公司的总负债总是明智的,但令人欣慰的是,深圳富力达科技的净现金为803万元人民币。我们喜欢去年息税前利润同比增长930%的样子。因此,我们对深圳FRD科技的债务使用并不感到困扰。随着时间的推移,股价往往会跟随每股收益,因此,如果你对深圳富瑞达科技感兴趣,你很可能想点击这里查看其每股收益历史的互动图表。

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

当一切都说完之后,有时更容易将注意力集中在甚至不需要债务的公司上。读者现在可以100%免费访问净负债为零的成长型股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发